Is Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) a Winner in the Medical Devices Industry?

A rating of 76 puts Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) near the top of the Medical Devices industry according to InvestorsObserver. Bio-Rad Laboratories, Inc. Class A Common Stock's score of 76 means it scores higher than 76% of stocks in the industry. Bio-Rad Laboratories, Inc. Class A Common Stock also received an overall rating of 54, putting it above 54% of all stocks. Medical Devices is ranked 83 out of the 148 industries.

BIO has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on BIO!

See Full BIO Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 54 means the stock is more attractive than 54 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes

InvestorsObserver

’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Bio-Rad Laboratories, Inc. Class A Common Stock Stock Today?

Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock is higher by 1.53% while the S&P 500 has fallen -0.01% as of 2:20 PM on Friday, Nov 19. BIO has gained $11.77 from the previous closing price of $771.20 on volume of 23,348 shares. Over the past year the S&P 500 is higher by 31.33% while BIO has gained 36.32%. BIO earned $220.42 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 3.54. Click Here to get the full Stock Report for Bio-Rad Laboratories, Inc. Class A Common Stock stock.